Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Sci Rep. 2023 Mar 3;13(1):3620. doi: 10.1038/s41598-023-30374-9.
No abstract available

Publication types

  • Published Erratum